Literature DB >> 20609112

Spatio-temporal deleted in colorectal cancer (DCC) and netrin-1 expression in human foetal brain development.

P N Harter1, B Bunz, K Dietz, K Hoffmann, R Meyermann, M Mittelbronn.   

Abstract

AIMS: Deleted in colorectal cancer (DCC) and its ligand netrin-1 are known as axonal guidance factors, being involved in angiogenesis, migration and survival of precursor cells in the embryonic mammalian central nervous system (CNS). So far, little is known about the distribution of those molecules in human CNS development.
METHODS: We investigated 22 human foetal brain specimens (12th and 28th week of gestation) for DCC and netrin-1 expression by means of immunohistochemistry, immunofluorescence and confocal laser microscopy. Statistical analysis was performed by applying a semi-quantitative score, including staining intensity and frequency and correlation with foetal age.
RESULTS: DCC and netrin-1 were differentially expressed throughout the developing human foetal telencephalic and cerebellar cortical layers. Netrin-1 exhibited the highest levels in telencephalic germinal layers, whereas the strongest DCC immunoreactivity was seen in the developing cortical plate. Netrin-1 and DCC were predominantly present on cerebellar external granule layer cells. Distinct co-expression was seen in maturing foetal brainstem nuclei, cerebellar external granular layer and the choroid plexus. In contrast, endothelial cells showed strong netrin-1 expression with subsidiary DCC immunoreactivity. Pontine and telencephalic axonal fibre tracts also demonstrated strong netrin-1 expression.
CONCLUSIONS: We show that DCC and netrin-1 are ubiquitously expressed in the human foetal brain; however, both exhibit a distinct spatio-temporal expression pattern. Together with the data from animal experiments, our findings might indicate also an important role for DCC and netrin-1 in human foetal CNS development.
© 2010 The Authors. Neuropathology and Applied Neurobiology © 2010 British Neuropathological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609112     DOI: 10.1111/j.1365-2990.2010.01100.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  19 in total

1.  Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.

Authors:  Julia Tichy; Sabrina Spechtmeyer; Michel Mittelbronn; Elke Hattingen; Johannes Rieger; Christian Senft; Christian Foerch
Journal:  J Neurooncol       Date:  2015-10-30       Impact factor: 4.130

Review 2.  Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system.

Authors:  Cecilia Flores
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

Review 3.  DCC mutation update: Congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndrome.

Authors:  Ashley P L Marsh; Timothy J Edwards; Charles Galea; Helen M Cooper; Elizabeth C Engle; Saumya S Jamuar; Aurélie Méneret; Marie-Laure Moutard; Caroline Nava; Agnès Rastetter; Gail Robinson; Guy Rouleau; Emmanuel Roze; Megan Spencer-Smith; Oriane Trouillard; Thierry Billette de Villemeur; Christopher A Walsh; Timothy W Yu; Delphine Heron; Elliott H Sherr; Linda J Richards; Christel Depienne; Richard J Leventer; Paul J Lockhart
Journal:  Hum Mutat       Date:  2017-11-11       Impact factor: 4.878

4.  Resilience to amphetamine in mouse models of netrin-1 haploinsufficiency: role of mesocortical dopamine.

Authors:  Matthew Pokinko; Luc Moquin; Angélica Torres-Berrío; Alain Gratton; Cecilia Flores
Journal:  Psychopharmacology (Berl)       Date:  2015-08-12       Impact factor: 4.530

5.  Pathological changes induced by phosphine poisoning: a study on 8 children.

Authors:  Yue Liang; Fang Tong; Fang Huang; Yuluo Liu; Longlong Zhu; Jehane Michael Le Grange; Guanglong He; Yiwu Zhou
Journal:  Int J Legal Med       Date:  2019-11-11       Impact factor: 2.686

6.  Mesocorticolimbic Connectivity and Volumetric Alterations in DCC Mutation Carriers.

Authors:  Daniel E Vosberg; Yu Zhang; Aurore Menegaux; Amanda Chalupa; Colleen Manitt; Simone Zehntner; Conrad Eng; Kristina DeDuck; Dominique Allard; France Durand; Alain Dagher; Chawki Benkelfat; Myriam Srour; Ridha Joober; Franco Lepore; Guy Rouleau; Hugo Théoret; Barry J Bedell; Cecilia Flores; Marco Leyton
Journal:  J Neurosci       Date:  2018-04-30       Impact factor: 6.167

7.  Signaling mechanisms in cortical axon growth, guidance, and branching.

Authors:  Katherine Kalil; Li Li; B Ian Hutchins
Journal:  Front Neuroanat       Date:  2011-09-28       Impact factor: 3.856

8.  Expression Profile of Sonic Hedgehog Pathway Members in the Developing Human Fetal Brain.

Authors:  Julia Tichy; Jenny Zinke; Benedikt Bunz; Richard Meyermann; Patrick N Harter; Michel Mittelbronn
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

9.  Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.

Authors:  Patrick N Harter; Jenny Zinke; Alexander Scholz; Julia Tichy; Cornelia Zachskorn; Hans M Kvasnicka; Benjamin Goeppert; Céline Delloye-Bourgeois; Elke Hattingen; Christian Senft; Joachim P Steinbach; Karl H Plate; Patrick Mehlen; Dorothea Schulte; Michel Mittelbronn
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

10.  Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

Authors:  Alexander Scholz; Patrick N Harter; Sebastian Cremer; Burak H Yalcin; Stefanie Gurnik; Maiko Yamaji; Mariangela Di Tacchio; Kathleen Sommer; Peter Baumgarten; Oliver Bähr; Joachim P Steinbach; Jörg Trojan; Martin Glas; Ulrich Herrlinger; Dietmar Krex; Matthias Meinhardt; Astrid Weyerbrock; Marco Timmer; Roland Goldbrunner; Martina Deckert; Christian Braun; Jens Schittenhelm; Jochen T Frueh; Evelyn Ullrich; Michel Mittelbronn; Karl H Plate; Yvonne Reiss
Journal:  EMBO Mol Med       Date:  2016-01-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.